Targeting the Wnt Canonical Pathway in Multiple Myeloma (MM) with BC2059, a New Orally Bioavailable -catenin Inhibitor

Saved in:
Bibliographic Details
Published in:Clinical lymphoma, myeloma and leukemia myeloma and leukemia, 2015-09, Vol.15, p.e211-e212
Main Authors: Savvidou, I, Khong, T, Horrigan, S, Spencer, A
Format: Article
Language:English
Subjects:
Hematology, Oncology and Palliative Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2152-2650
2152-2669
DOI:10.1016/j.clml.2015.07.458